BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates

Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesity

Source: BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates